Clinical trial
Postgrafting Methotrexate and Cyclosporine for the Prevention of Graft-Versus-Host Disease
NCT00002456 is registered in ClinicalTrials.gov with Fred Hutchinson Cancer Center as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Postgrafting Methotrexate and Cyclosporine for the Prevention of Graft-Versus-Host Disease
- Lead sponsor
- Fred Hutchinson Cancer Center
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 1986
- Completion date
- April 30, 2002
- Enrollment
- Not reported
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.